Bladder cancer is the fifth most common cancer in men and ninth in women (Droller, 1998). Despite much research on the topic, it is still difficult to predict tumour progression, optimal therapy and ...

The reduction or loss of plakoglobin expression in late-stage bladder cancer has been correlated with poor survival where upregulation of this catenin member by histone deacetylase inhibitors has been ...